This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
Summary of, and comparison with, existing or proposed federal regulation: None
Comparison with rules in adjacent states:
Illinois: Illinois does not have rules regarding technician-check-technician.
Iowa: Iowa has rules regarding technician-check-technician. The technician must have active Iowa registration, hold national technician certification, have experience as a technician and trained in technician-check-technician (including medication errors). There shall be a supervising pharmacist. The pharmacy is required to have policies and procedures in place and maintain records. The drug utilization review must be performed by a pharmacist. The medication checked by a technician must be checked by a licensed health care practitioner prior to administration.
Michigan: Michigan does not have rules regarding technician-check-technician.
Minnesota: Minnesota does not have rules regarding technician-check-technician.
Summary of factual data and analytical methodologies:
The Pharmacy Examining Board began a pilot program for delegate-check-delegate on October 1, 2016. The purpose was to study the accuracy and determine whether delegate-check-delegate improves the safety, quality or efficiency of the practice of pharmacy. The Pharmacy Examining Board determined that the procedures utilized in the pilot program were sufficient for the safety of the public and is amending the rules to allow for this practice.
The Pharmacy Examining Board also received information from the Pharmacy Society of Wisconsin’s community delegate-check-delegate study.
Analysis and supporting documents used to determine effect on small business or in preparation of economic impact analysis:
This rule was posted for economic comments and none were received. This rule does not require a pharmacy to utilize delegate-check-delegate process in the pharmacy.
Fiscal Estimate and Economic Impact Analysis:
The Fiscal Estimate and Economic Impact Analysis is attached.
Effect on small business:
These proposed rules do not have an economic impact on small businesses, as defined in s. 227.114 (1), Stats. The Department’s Regulatory Review Coordinator may be contacted by email at Daniel.Hereth@wisconsin.gov, or by calling (608) 267-2435.
Agency contact person:
Sharon Henes, Administrative Rules Coordinator, Department of Safety and Professional Services, Division of Policy Development, 4822 Madison Yards Way, P.O. Box 8366, Madison, Wisconsin 53708; telephone 608-261-2377; email at DSPSAdminRules@wisconsin.gov.
Place where comments are to be submitted and deadline for submission:
Comments may be submitted to Sharon Henes, Administrative Rules Coordinator, Department of Safety and Professional Services, Division of Policy Development, 4822 Madison Yards Way, P.O. Box 8366, Madison, WI 53708-8366, or by email to DSPSAdminRules@wisconsin.gov. Comments must be received on or before October 23, 2019 to be included in the record of rule-making proceedings.
------------------------------------------------------------------------------------------------------------
TEXT OF RULE
Section 1. Phar 7.21 is created to read:
Phar 7.21 Delegate-check-delegate. (1) Definitions. In this section:
(a)
“Delegate” means a person to whom the pharmacist has delegated the task of product verification.
(b)
“Delegate-check-delegate” means the process in which one delegate conducts the task of product verification of technical dispensing functions completed by an unlicensed individual. A delegate may not conduct product verification as part of the final check of their own product preparation.
(c)
“Product verification” means doing a check of the accuracy and correctness of a product, including drug, strength, formulation, and expiration or beyond use date, as part of the final check.
(d)
“Supervising pharmacist” means the pharmacist licensed in this state, who is responsible for the operations and outcomes of product verification done by a delegate and ensuring for direct supervision of the delegate.
(2) Delegate qualifications. A pharmacist may delegate the product verification of a prescription or chart order to a delegate who meets all of the following:
  (a) Is at least 18 years old.
  (b) Completed an accredited technician training program or has a minimum of 500 hours of experience in product selection, labeling and packaging.
  (c) Completed a didactic and practical training curriculum approved by the supervising and managing pharmacist that includes training in all of the following:
1. Elements of correct product including all of the following:
  a. Drug name.
  b. Strength.
  c. Formulation.
  d. Expiration date.
  e. Beyond use date.
2. Common dispensing medication errors and concepts including all of the following:
a. Wrong medication.
b. Wrong strength.
c. Wrong formulation.
d. Extra or insufficient quantity.
e. Omitted medications if utilizing unit dose or compliance packaging.
f. Expired medication.
g. Look-alike or sound-alike errors.
h. High-alert medications.
    3. Eligible medications for delegate-check-delegate.
4. Organizational policies and procedures on reporting of medication errors.
5. Overview of the medication use process including all of the following:
a. Procurement.
b. Ordering.
c. Dispensing.
d. Administration.
e. Monitoring.
6. A practical training designed to assess the competency of the delegate prior to starting the validation process. The practical training shall include simulation of at least two occurrences of each of the following:
    a. Wrong drug.
    b. Wrong strength.
    c. Wrong formulation.
  d. Omitted medication, if utilizing unit dose or compliance packaging.
  (d) Completed the following validation process:
  1. The delegate being validated shall make a product verification on the work of a pharmacist or unlicensed person for accuracy and correctness of a minimum of 500 product verifications over a minimum of 5 separate days and achieve an accuracy rate of at least 99.8%.
  2. A pharmacist shall audit 100% of the product verifications made by the delegate during the validation process.
  (e) Notwithstanding, par (a) to (d), a delegate who completed the pilot program validation process between October 1, 2016 and September 30, 2019 meets the delegation qualifications unless the delegate fails to meet the quality assurance standards under sub. (4)
(3) Eligible product. (a) Institutional pharmacies. The delegate may do the product verification in an institutional pharmacy if the product meets all of the following:
  1. Is in an original package from a manufacturer or if the licensed pharmacist has ensured that any repackaging of stock results in a package that is labeled with the correct drug name, strength, formulation, control or lot number, and beyond use date.
  2. Has a drug utilization review performed by a pharmacist prior to dispensing.
  3. Will be administered by an individual authorized to administer medications at the institution where the medication is administered.
  (b) Community pharmacies. The delegate may do the product verification in a community pharmacy if the medications meets all of the following:
Loading...
Loading...
Links to Admin. Code and Statutes in this Register are to current versions, which may not be the version that was referred to in the original published document.